Maternal serum free β-hCG and PAPP-A in fetal sex chromosome defects in the first trimester

被引:2
|
作者
Spencer, K
Tul, N
Nicolaides, KH
机构
[1] Harold Wood Hosp, Dept Clin Biochem, Endocrine Unit, Romford RM3 0BE, Essex, England
[2] Kings Coll Hosp London, Sch Med, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England
关键词
biochemical screening; Turner's syndrome; nuchal translucency;
D O I
10.1002/(SICI)1097-0223(200005)20:5<390::AID-PD824>3.0.CO;2-B
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We have studied maternal serum free beta-hCG and PAPP-A, and fetal nuchal translucency (NT) in a series of 46 cases of fetal Turner's syndrome, 13 cases of other sex chromosomal anomalies and compared these with 947 control pregnancies in the first trimester. In cases of Turner's syndrome (45,X) the median fetal NT was significantly higher than in controls (4.76 MoM), the median PAPP-A was significantly lower (0.49 MoM), whilst the free beta-hCG was not significantly different (1.11 MoM). For NT, 93% (43/46) of cases were equal to or greater than the 95th centile of controls, for PAPP-A 35% (16/46) of cases were less than or equal to the 5th centile of controls and for free beta-hCG 15% (7/46) of cases were equal to or greater than the 95th centile of controls. For other sex chromosomal anomalies (47XXX, XXY, XYY) the median NT was increased (2.07 MoM) whilst PAPP-A was not significantly decreased (0.88 MoM) and free beta-hCG was not significantly different (1.07 MoM) from controls. Using a previously derived multivariate risk algorithm for trisomy 21, incorporating NT, PAPP-A, free beta-hCG and maternal age, 96% of the Turner's cases and 62% of the other sex chromosomal anomalies would have been identified. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
下载
收藏
页码:390 / 394
页数:5
相关论文
共 50 条
  • [41] First trimester PAPP-A and the risk of fetal growth restriction
    Sovio, Ulla
    Smith, Gordon
    Dacey, Alison
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S112 - S112
  • [42] Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A
    Spencer, K
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2001, 108 (10): : 1043 - 1046
  • [44] 449 Low Maternal Levels of First Trimester Papp-A and Free β-Hcg are Associated with An Increased Risk of Adverse Neonatal Outcome
    I Kirkegaard
    N Uldbjerg
    T B Henriksen
    Pediatric Research, 2010, 68 : 230 - 231
  • [45] Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening
    L. Berktold
    C. v. Kaisenberg
    P. Hillemanns
    B. Vaske
    P. Schmidt
    Archives of Gynecology and Obstetrics, 2013, 287 : 413 - 420
  • [46] Higher median levels of free β-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group
    Leung, TY
    Spencer, K
    Leung, TN
    Fung, TY
    Lau, TK
    FETAL DIAGNOSIS AND THERAPY, 2006, 21 (01) : 140 - 143
  • [47] Screening for triploidy by fetal nuchal translucency and maternal serum free β-hCG and PAPP-A at 10-14 weeks of gestation
    Spencer, K
    Liao, AWJ
    Skentou, H
    Cicero, S
    Nicolaides, KH
    PRENATAL DIAGNOSIS, 2000, 20 (06) : 495 - 499
  • [48] Analysis of first trimester markers, PAPP-A and free-βhCG, and adverse outcomes in twin pregnancies
    Fathian, Asal
    Miller, Richard
    Wolf, Edward
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (01) : S135 - S135
  • [49] First Trimester PAPP-A and β-hCG in Different Subtypes of Placental Syndrome.
    Nijhuis, Margot
    Vrencken, Marjolein
    Ghossein-Doha, Chahinda
    Spaanderman, Marc
    Al-Nasiry, Salwan
    REPRODUCTIVE SCIENCES, 2015, 22 : 386A - 386A
  • [50] Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia
    Spencer, Kevin
    Cowans, Nicholas J.
    Nicolaides, Kypros H.
    PRENATAL DIAGNOSIS, 2008, 28 (01) : 7 - 10